About Us

Prime Behavior Testing Laboratories (PBTLI) was formed in March 2000 by three pharmaceutical researchers and a certified public accountant (CPA), combining years of research experience and collaboration with members of the industry. PBTLI scientists have over 18 years of experience conducting contract studies, following industry standards of speed, confidentiality, and reliability.

Alvin V. Terry, Jr., Ph.D.

President and CEO

Dr. Terry is a tenured Regents Professor and the Chair of the Department of Pharmacology and Toxicology at the Medical College of Georgia at Augusta University (AU) in Augusta, Georgia, USA. He also holds joint appointments as Professor of Neurology and Graduate Studies at AU and is a licensed pharmacist in Georgia and South Carolina. He has more than 25 years of research experience in neuropharmacology, drug discovery, and neurotoxicology, and he has conducted numerous collaborative projects and contracts with the pharmaceutical industry.

Regina Buccafusco

First Vice President

Regina Buccafusco, wife of the Late Dr. Buccafusco, has served as an officer of PBLTI since its inception in 2000. She has experience as a laboratory technician and as an Information Media Specialist of MCG Health, Inc. She has also been a member of the Columbia County Board of Education in Georgia since 1998 and has served as its Chairman since 2008.

Lowell Greenbaum, Ph.D.

Second Vice President

Dr. Greenbaum, Professor Emeritus and former Vice President for Research at the Medical College of Georgia, has over 40 years of research experience in pharmacology and biochemistry and is internationally recognized for his accomplishments as a researcher as well as for his leadership roles in the field. Dr. Greenbaum has served on the board of directors of several organizations that served to facilitate interactions and joint ventures between academia and industry.

Patrick M Callahan MS


Patrick Callahan is the Manager of the Small Animal Behavior Core (SABC), an institutional core facility at Augusta University (AU). He also holds the faculty rank of Research Scientist in the Department of Pharmacology and Toxicology at the Medical College of Georgia at AU. He had more than 20 years of previous drug discovery experience working in the pharmaceutical industry before joining the faculty of AU in 2010.

William F. Bruggemann, III


Mr. Bruggemann has served as Chief Financial Officer of PBLTI since its inception in 2000. He has over 30 years of experience as a certified public accountant for private companies as well as the armed services.

  • More About PBTLI

    PBTLI is a pre-clinical contract research organiztion (CRO) that provides rapid pre-clinical testing to pharmaceutical, biotechnology, and medical device companies for facilitating new product development.

  • Need a Quote?

    Please visit our contact page to get in touch.

    Get a Quote
  • Latest News

    • New Journal Article Published:

      Crider A, Nelson T, Davis T, Fagan K, Vaibhav K, Luo M, Kamalasanan S, Terry AV Jr, Pillai A. Estrogen Receptor β Agonist Attenuates Endoplasmic Reticulum Stress-Induced Changes in Social Behavior and Brain Connectivity in Mice. Molecular Neurobiology 55(9):7606-7618, 2018.

Copyright ©2019 Prime Behavior Testing Laboratories, Inc
^ Back to Top